Biotech · Private company

Xerient Pharma

Track this companyFree. Adds Xerient Pharma to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials

Pipeline1

Clinical trials1

  • A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.PHASE1_PHASE2 · RECRUITING · started Jan 1, 2026ClinicalTrials.gov NCT07157033 · fetched Nov 12, 2026